Overlevelsesprocenten var størst hos dem, der fik Cyanokit, før de fik hjer - testop, dem, der havde mindre svære symptomer på hjerneskade, og dem med lavere cyanidindhold i blodet.
Survival was more likely in those who received Cyanokit before their hearts had stopped, who had less severe symptoms of brain damage and who had lower blood cyanide levels.